EFFICACY OF VALSARTAN PLUS AMLODIPINE VERSUS VALSARTAN PLUS HYDROCHLOROTHIAZIDE FOR CONTROL OF MODERATE TO SEVERE HYPERTENSION: A RANDOMIZED CONTROLLED TRIAL
DOI:
https://doi.org/10.47144/phj.v50i1.1220Abstract
Objective: To compare of the efficacy of valsartan plus amlodipine versusvalsartan plus hydrochlorothiazide for control of moderate to severehypertension.
Methodology: This randomized controlled trial was conducted at Department ofCardiology, Lady Reading Hospital Peshawar from 1 January, 2015 to 30 June,2015. All patients with stage 2 hypertension of either gender were randomlyassigned into two groups. Patients in group A were subjected to combination ofvalsartan 160 mg plus amlodipine 10 mg and patients in group B were subjectedto the combination of valsartan 160 mg plus hyrochlorothiazide 25 mg . Patientswere selected by non probability purposive technique. All patients were followedfor 4 weeks.
Results: A total of 88 patients were included in this study. Mean age in bothgroups was 65±1.26 years. In group A, 27(62%) patients were males, where asin group B, 26(60%) patients were males. Valsartan+Amlodipine was effectivein 32(72%) cases and was not effective in 12(28%) cases while Valsartan +Hydrochlorothiazide was effective in 35(80%) cases and was not effective in9(20%) cases (p=0.2).
Conclusion: Both combinations had similar anti-hypertensive effects, howeverValsartan+Hydrochlorothiazide combination had a better therapeutic profile asit showed fewer side effects and less treatment dropout than Valsartan +Amlodipine combination.
Downloads
Downloads
How to Cite
Issue
Section
License
When an article is accepted for publication in the print format, the author will be required to transfer exclusive copyright to the PHJ and retain the rights to use and share their published article with others. However, re-submission of the full article or any part for publication by a third party would require prior permission of the PHJ.
Online publication will allow the author to retain the copyright and share the article under the agreement described in the licensing rights with creative commons, with appropriate attribution to PHJ. Creative Commons attribution license CC BY 4.0 is applied to articles published in PHJ https://creativecommons.org/licenses/by/4.0/